• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Biosimilars: Overview of Legislation, Policy, and Current State of Implementation


Biosimilar Webcast 1

Enduring Webcast: Biosimilars: Overview of Legislation, Policy and Current State of Implementation

This webcast was brought to you by Amgen.

The faculty for this webcast:

  • Defined therapeutic equivalence for small molecule generics
  • Described how biologics differ from small molecule drugs
  • Explained how the Biologics Price Control and Innovation Act amends the Public Health Service Act and the key requirements of the US biosimilars pathway
  • Discussed the difference between biosimilarity and interchangeability
  • Reviewed the US legislation for intellectual property and payment provisions

Length of webcast: 14 minutes

System Requirements

PC-based attendees

Required: Windows® 7, Vista, XP, 2003 Server or 2000

Macintosh®-based attendees

Required: Mac OS® X 10.4.11 (Tiger®) or newer


Related Videos
Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions
dr kimberly maxfield
Amal Trivedi, MD
Dr. Jorge Garcia
Ted Okon, MBA, Community Oncology Alliance
Lalan Wilfongd, MD, US Oncology Network
dr kimberly maxfield
Bincy Abraham, MD
Allister Chang, co-founder, Fabric Health
Related Content
© 2023 MJH Life Sciences
All rights reserved.